PERSPECTA

News from every angle

Back to headlines

Doliprane Recall for Infants Due to Pipette Manufacturing Defect

Batches of drinkable Doliprane for infants and young children are being recalled in France due to a manufacturing defect where the graduations on the pipettes can gradually erase after rinsing.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.